Where Should Radiotherapy Stand in the Current Era of Rectal Cancer Management?

Turk Onkoloji Dergisi - Turkey
doi 10.5505/tjo.2018.1796
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

LookUs Bilisim A.S.

Related search

Transplantation Tolerance: The Big Picture. Where Do We Stand, Where Should We Go?

Clinical and Experimental Immunology
AllergyImmunology
2017English

In the Era of Total Mesorectal Excision: Adjuvant Radiotherapy May Be Unnecessary for pT3N0 Rectal Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Where Do the Immune Checkpoint Inhibitors Stand in the Management of Triple Negative Breast Cancer?

Immunotherapy
OncologyAllergyImmunology
2018English

Government Policy and Technological Innovation: Where Do We Stand and Where Should We Go?

1977English

Targeting Angiogenesis in Cancer Treatments: Where Do We Stand?

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2016English

Intraoperative Radiotherapy for Locally Advanced Rectal Cancer

Journal of the Korean Society of Coloproctology
2010English

Developments in Neoadjuvant Chemotherapy and Radiotherapy in Rectal Cancer

2012English

The Great Debate on Nurse-Administered Propofol Sedation (NAPS)—Where Should We Stand?

Anesthesia Progress
AnesthesiologyPain Medicine
2006English

Management of Locoregional Rectal Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy